- Release Date: 18/02/19 09:19
- Summary: NNZ-2591 positive effects in Phelan-McDermid syndrome model
- Price Sensitive: Yes
- Download Document 109KB
- Forums
- ASX - By Stock
- NEU
- Ann: NNZ-2591 positive effects in Phelan-McDermid syndrome model
Ann: NNZ-2591 positive effects in Phelan-McDermid syndrome model
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.12 |
Change
-0.270(1.39%) |
Mkt cap ! $2.440B |
Open | High | Low | Value | Volume |
$19.55 | $19.65 | $18.88 | $4.650M | 243.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 598 | $19.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.12 | 41 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 469 | 19.120 |
9 | 1329 | 19.110 |
6 | 693 | 19.100 |
5 | 463 | 19.090 |
5 | 1113 | 19.080 |
Price($) | Vol. | No. |
---|---|---|
19.130 | 202 | 7 |
19.140 | 474 | 7 |
19.150 | 467 | 6 |
19.160 | 4219 | 9 |
19.170 | 8357 | 4 |
Last trade - 13.37pm 31/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online